Skip to main content
. 2022 Nov 7;27(1):249–258. doi: 10.1080/13510002.2022.2139947

Figure 5.

Figure 5.

Immunohistopathological examination for TGF-β1 expression in kidney tissues. (A) The score of TGF-β1 in all studied groups, (B) negative expression for TGF-β1 (control group, 400×), (C) marked cytoplasmic expression for TGF-β1 in both renal tubules and glomeruli (CKD group, 200×), (D) moderate expression of TGF-β1 in SPL group (200×), (E) mild expression of TGF-β1 in ZnO-NPs group (200×), and (F) mild expression in SPL + ZnO-NPs group (200×). a: significant difference versus control, b: significant versus CKD, c: significant versus SPL, d: significant versus ZnO-NPs at p < 0.05.